Literature DB >> 18986757

Neuralgic amyotrophy associated with hepatitis E virus.

Farina Fong1, Memon Illahi.   

Abstract

Neuralgic amyotrophy (NA) is characterised by neuropathic pain and patchy paresis of the upper or lower limbs, usually involving the upper and middle trunks of the brachial plexus. The aetiology of NA is varied, with precipitating factors that include trauma, surgery, pregnancy, inoculations and infections. Deranged liver enzymes have been noted in previous NA reports but no cause identified. We describe a case of bilateral NA in a 53-year-old man who presented with peripheral neuropathy and isolated derangement of liver enzymes. Serology was positive for hepatitis E infection and negative for other infections previously described to be associated with NA. The diagnosis was supported by electrophysiological findings. This case report suggests that hepatitis E is a potential cause of NA that had not previously been described in the literature, and further supports a proposed immune pathogenesis underlying the condition.

Entities:  

Mesh:

Year:  2008        PMID: 18986757     DOI: 10.1016/j.clineuro.2008.09.005

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  22 in total

1.  Neuralgic amyotrophy and hepatitis E virus infection.

Authors:  Jeroen J J van Eijk; Richie G Madden; Annemiek A van der Eijk; Jeremy G Hunter; Johan H J Reimerink; Richard P Bendall; Suzan D Pas; Vic Ellis; Nens van Alfen; Laura Beynon; Lucy Southwell; Brendan McLean; Bart C Jacobs; Baziel G M van Engelen; Harry R Dalton
Journal:  Neurology       Date:  2014-01-08       Impact factor: 9.910

Review 2.  Hepatitis E: an old infection with new implications.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Maria Bianchi; Gabriele Calizzani; Fabio Candura; Liviana Catalano; Blandina Farina; Monica Lanzoni; Vanessa Piccinini; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

Review 3.  Chronic hepatitis e virus infection and treatment.

Authors:  Nassim Kamar; Jacques Izopet; Harry R Dalton
Journal:  J Clin Exp Hepatol       Date:  2013-05-25

Review 4.  Hepatitis E virus and neurological injury.

Authors:  Harry R Dalton; Nassim Kamar; Jeroen J J van Eijk; Brendan N Mclean; Pascal Cintas; Richard P Bendall; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2015-12-29       Impact factor: 42.937

Review 5.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 6.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

7.  Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection.

Authors:  S Cronin; R McNicholas; E Kavanagh; V Reid; K O'Rourke
Journal:  Ir J Med Sci       Date:  2010-11-10       Impact factor: 1.568

8.  Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient.

Authors:  A Velay; W Kack-Kack; F Abravanel; S Lhomme; P Leyendecker; L Kremer; P Chamouard; J Izopet; S Fafi-Kremer; H Barth
Journal:  J Neurovirol       Date:  2017-04-24       Impact factor: 2.643

9.  Transverse myelitis caused by hepatitis E: previously undescribed in adults.

Authors:  Pamela Sarkar; Catherine Morgan; Samreen Ijaz
Journal:  BMJ Case Rep       Date:  2015-07-06

Review 10.  Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype.

Authors:  Quentin Scanvion; Thierry Perez; François Cassim; Olivier Outteryck; Aurélia Lanteri; Pierre-Yves Hatron; Marc Lambert; Sandrine Morell-Dubois
Journal:  J Neurol       Date:  2017-02-28       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.